New pandemic in 2026?

Currently, the prevailing sentiment in this market suggests a relatively low probability of a new pandemic in 2026. This contrasts with some analyst forecasts, which, depending on the modeling assumptions, may suggest a higher or lower risk. It’s important to note that analyst predictions are often based on complex models and expert opinion, while this market reflects the collective judgment of a diverse group of traders. The difference between these perspectives can highlight varying interpretations of available data and potential future events.

On Polymarket, this market is priced through a continuous auction mechanism, where traders buy and sell shares representing their belief about the likelihood of a new pandemic in 2026. The price of these shares directly reflects the implied probability of the event occurring. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The market’s price fluctuates based on supply and demand, driven by new information, changing sentiment, and trading activity. Currently, the top outcome, 'New pandemic in 2026?', has a chance percentage of 4.0%.

This market resolves around Jan 1, 2027, with the outcome confirmed once the event is verifiable from credible public reporting. Resolution will depend on whether a novel pathogen emerges and causes widespread, sustained transmission, meeting the definition of a pandemic as determined by relevant health organizations. The outcome will be based on publicly available data and reports from established sources, ensuring a transparent and objective assessment of whether a new pandemic occurred in 2026.

Several signals or events could significantly impact this market. The emergence of a novel infectious disease, even in a limited geographic area, would likely cause the odds to increase. Conversely, positive developments in vaccine technology or improved global pandemic preparedness efforts could lower the perceived risk. Major reports from organizations like the World Health Organization (WHO) or the Centers for Disease Control and Prevention (CDC) regarding emerging infectious diseases would also be influential. Unexpected outbreaks of known diseases could also shift the market.